Sarda Proteins has expanded the agenda for its upcoming Extraordinary General Meeting (EGM) to include the appointment of a statutory auditor and the regularization of a woman independent director. The meeting is scheduled for July 30, 2026, at 11:00 A.M. via Video Conferencing. These additions, approved by the Board on July 15, 2026, require shareholder consent to finalize the appointments and ensure compliance with the Companies Act, 2013.

Statutory Auditor Appointment

The company proposes appointing M/s A H Mandaliya & Associates (firm registration number 022073N) to fill a casual vacancy caused by the resignation of the previous auditor. This appointment, recommended by the Board on November 26, 2025, will be effective from the conclusion of the EGM. The firm will conduct the statutory audit for the period ended March 31, 2026.

Shareholders are also asked to approve the appointment of M/s A H Mandaliya & Associates for the first term of five years, commencing from the conclusion of this EGM until the Annual General Meeting for FY 2030-31. The auditors have confirmed their eligibility and that their appointment falls within the limits prescribed under Section 141 of the Companies Act, 2013.

Independent Director Regularization

The EGM agenda includes the regularization of Ms. Minal Surendra Jain (DIN: 11822395) as a Woman Independent Director. She was initially appointed as an Additional Director by the Board on July 15, 2026. Upon shareholder approval, she will hold office for a term of five consecutive years effective from July 15, 2026.

Ms. Jain, aged 26, is a graduate and a semi-qualified Company Secretary with expertise in corporate compliance, governance, and regulatory reporting. She has confirmed that she meets the independence criteria specified under Section 146(9) of the Companies Act, 2013. None of the other directors or key managerial personnel are interested in these resolutions.

Key Agenda Items

Sarda Proteins Limited returned to profitability in the first quarter of FY26, reporting a net profit of ₹165.97 lakh for the period ended June 30, 2026. This marks a significant recovery from the net loss of ₹49.34 lakh recorded in the corresponding quarter of the previous year. Total revenue for the quarter stood at ₹1,847.40 lakh, a sharp increase compared to ₹1,095.54 lakh in Q1FY25, driven primarily by a rise in revenue from operations to ₹1,299.30 lakh.

The company's board approved the unaudited standalone financial results during a meeting held on July 15, 2026. The results were reviewed by the statutory auditor, A H Mandaliya & Associates, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The auditor confirmed that the statement complies with Indian Accounting Standard (Ind AS) 34 and contains no material misstatement.

Financial Performance

The turnaround in profitability was supported by a substantial increase in other income, which rose to ₹548.10 lakh from ₹0.08 lakh in the prior year quarter. Total expenses for the quarter were ₹1,626.10 lakh. The company reported a profit before tax of ₹221.30 lakh, with a current tax expense of ₹55.33 lakh recorded for the period.

Corporate Governance Decisions

Alongside the financial results, the board approved several key governance and administrative changes. Ms. Minal Surendra Jain was appointed as an Independent Women Director for a term of five years, effective July 15, 2026, subject to shareholder approval. The board also reconstituted the Audit Committee, Nomination and Remuneration Committee, and Stakeholders' Relationship Committee with immediate effect.

Administratively, the company approved the shifting of its registered office within Alwar, Rajasthan, to a new location effective July 15, 2026. Additionally, the board sanctioned the establishment of a new corporate office in Rajkot, Gujarat, commencing operations on the same date. The company noted that it operates in a single segment, the Renewable Energy Sector Solar Cell Products.